Hisamitsu Pharmaceutical Co Inc (4530):企業の製品パイプライン分析

◆英語タイトル:Hisamitsu Pharmaceutical Co Inc (4530) - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME80696PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥171,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥256,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Hisamitsu Pharmaceutical Co Inc (Hisamitsu Pharmaceutical) is a pharmaceutical company that provides pain management products. The company manufactures and sells pain relieving products, dermatological products, and quasi drugs, among others. Hisamitsu Pharmaceutical provides its products in various forms: patches, gel-patchs, gels, creams and lotions. Its products are indicated to relieve patients from stiff neck, sore shoulders, arthritis, joint pain backache, strains, sprains, muscle fatigue, bruises, muscle pain, simple backache bruises, stiff shoulders, sprains, strains arthritis, bone fracture, and minor frostbite. It operates production facilities, research laboratories, and offices in Japan. The company markets its products in Asia, Europe, Middle East & Africa, and the Americas. Hisamitsu Pharmaceutical is headquartered in Tosu, Kyushu, Japan.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Hisamitsu Pharmaceutical Co Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Hisamitsu Pharmaceutical Co Inc Company Overview
Hisamitsu Pharmaceutical Co Inc Company Snapshot
Hisamitsu Pharmaceutical Co Inc Pipeline Products and Ongoing Clinical Trials Overview
Hisamitsu Pharmaceutical Co Inc – Pipeline Analysis Overview
Business Description
Hisamitsu Pharmaceutical Co Inc – Key Facts
Hisamitsu Pharmaceutical Co Inc – Major Products and Services
Hisamitsu Pharmaceutical Co Inc Pipeline Products by Development Stage
Hisamitsu Pharmaceutical Co Inc Pipeline Products Overview
ATS Adhesive Skin Patch
ATS Adhesive Skin Patch Product Overview
Fentos Tape – Pediatrics
Fentos Tape – Pediatrics Product Overview
HARUROPI TAPE
HARUROPI TAPE Product Overview
HP-1010 Adhesive Skin Patch
HP-1010 Adhesive Skin Patch Product Overview
HP-1030 Adhesive Skin Patch
HP-1030 Adhesive Skin Patch Product Overview
HP-3150 Adhesive Skin Patch
HP-3150 Adhesive Skin Patch Product Overview
HP-5000 Adhesive Skin Patch
HP-5000 Adhesive Skin Patch Product Overview
HP-5070 Adhesive Skin Patch
HP-5070 Adhesive Skin Patch Product Overview
HTU-520 Patch
HTU-520 Patch Product Overview
Lidocaine Topical Patch
Lidocaine Topical Patch Product Overview
Hisamitsu Pharmaceutical Co Inc – Key Competitors
Hisamitsu Pharmaceutical Co Inc – Key Employees
Hisamitsu Pharmaceutical Co Inc – Key Employee Biographies
Hisamitsu Pharmaceutical Co Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Recent Developments
Hisamitsu Pharmaceutical Co Inc, Recent Developments
Dec 16, 2019: Hisamitsu Pharmaceutical: Notification of marketing of HARUROPI TAPE in Japan
Nov 28, 2019: Financial support to SAGA Heavy Ion Medical Accelerator in Tosu Project
Oct 15, 2019: U.S. FDA approves SECUADO (asenapine) Transdermal System, the First-and-Only Transdermal Patch for the treatment of adults with Schizophrenia
Sep 23, 2019: Noven announces appointment of Dr. Naruhito Higo as chief executive officer
Sep 20, 2019: Kyowa Kirin announces approval of new transdermal patch HARUROPI TAPE (HP-3000) for Parkinson’s Disease in Japan
Aug 29, 2019: Kyowa Kirin announces an partial change approval application of FENTOS TAPE (Code: HFT-290) Submission by Hisamitsu Pharmaceutical in Japan
Jul 11, 2019: Noven announces appointment of Andrew J. Purcell as head of marketing & sales
May 20, 2019: Categorical response and clinical relevance as assessed in a phase III study of HP-3070 (Asenapine) transdermal patch for the treatment of schizophrenia to be presented at the American Psychiatric Association 172nd Annual Meeting
Dec 14, 2018: Notification of the results of phase III clinical study in Opioid Analgesic NaiVe patients of the Transdermal, Pain Management Patch FENTOSTAPE (Development Code:HFT-290)
Oct 22, 2018: Notification of the commencement of the phase II clinical study of HP-5070 in Japan (A transdermal drug for the treatment of primary local hyperhidrosis)
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Hisamitsu Pharmaceutical Co Inc Pipeline Products and Ongoing Clinical Trials Overview
Hisamitsu Pharmaceutical Co Inc Pipeline Products by Equipment Type
Hisamitsu Pharmaceutical Co Inc Pipeline Products by Indication
Hisamitsu Pharmaceutical Co Inc, Key Facts
Hisamitsu Pharmaceutical Co Inc, Major Products and Services
Hisamitsu Pharmaceutical Co Inc Number of Pipeline Products by Development Stage
Hisamitsu Pharmaceutical Co Inc Pipeline Products Summary by Development Stage
ATS Adhesive Skin Patch - Product Status
ATS Adhesive Skin Patch - Product Description
Fentos Tape - Pediatrics - Product Status
Fentos Tape - Pediatrics - Product Description
HARUROPI TAPE - Product Status
HARUROPI TAPE - Product Description
HP-1010 Adhesive Skin Patch - Product Status
HP-1010 Adhesive Skin Patch - Product Description
HP-1030 Adhesive Skin Patch - Product Status
HP-1030 Adhesive Skin Patch - Product Description
HP-3150 Adhesive Skin Patch - Product Status
HP-3150 Adhesive Skin Patch - Product Description
HP-5000 Adhesive Skin Patch - Product Status
HP-5000 Adhesive Skin Patch - Product Description
HP-5070 Adhesive Skin Patch - Product Status
HP-5070 Adhesive Skin Patch - Product Description
HTU-520 Patch - Product Status
HTU-520 Patch - Product Description
Lidocaine Topical Patch - Product Status
Lidocaine Topical Patch - Product Description
Hisamitsu Pharmaceutical Co Inc, Key Employees
Hisamitsu Pharmaceutical Co Inc, Key Employee Biographies
Hisamitsu Pharmaceutical Co Inc, Other Locations
Hisamitsu Pharmaceutical Co Inc, Subsidiaries
Hisamitsu Pharmaceutical Co Inc, Joint Venture
Glossary

★海外企業調査レポート[Hisamitsu Pharmaceutical Co Inc (4530):企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PG&E Corporation:企業の戦略・SWOT・財務情報
    PG&E Corporation - Strategy, SWOT and Corporate Finance Report Summary PG&E Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Astex Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Astex Pharmaceuticals Inc (Astex Pharmaceuticals), is a novel drug discovery and development company with a focus on cancer and central nervous system (CNS) diseases. It discovers and develops small molecule treatments. The company’s lead product, Dacogen (indicated for the treatment of myel …
  • Centre for Drug Design and Discovery:製薬・医療:M&Aディール及び事業提携情報
    Summary Centre for Drug Design and Discovery (CD3) is a biomedical research institution that discovers new small molecule drugs. The institution operates as an investment fund and technology transfer platform to promote the discovery and development of medicines for all kinds of diseases. It provide …
  • Yuanta Financial Holding Co., Ltd.:戦略・SWOT・企業財務分析
    Yuanta Financial Holding Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Yuanta Financial Holding Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Reply S.p.A. (REY):企業の財務・戦略的SWOT分析
    Reply S.p.A. (REY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Heron Resources Ltd:企業の戦略・SWOT・財務分析
    Heron Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Heron Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Carmat SAS (ALCAR):企業の財務・戦略的SWOT分析
    Summary Carmat SAS (Carmat) is a medical equipment company that provides artificial organs. The company provides development of innovative artificial organs, artificial heart and other vital organs, among others. Carmat artificial heart products consist of an implantable heart. The company offers co …
  • Calgro M3 Holdings Ltd:企業の戦略・SWOT・財務情報
    Calgro M3 Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Calgro M3 Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Tongaat Hulett Ltd (TON):企業の財務・戦略的SWOT分析
    Tongaat Hulett Ltd (TON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Mundipharma International Ltd:企業の戦略的SWOT分析
    Mundipharma International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Buck Institute for Research on Aging:製薬・医療:M&Aディール及び事業提携情報
    Summary Buck Institute for Research on Aging (Buck Institute) is a biomedical institute that conducts research on aging and chronic disease. The institute concentrates on understanding the connection between aging and chronic disease. It carries out research and develops treatments in the therapeuti …
  • Renewable Energy Group, Inc.:企業の戦略・SWOT・財務分析
    Renewable Energy Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Renewable Energy Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Gran Tierra Energy Inc. (GTE):石油・ガス:M&Aディール及び事業提携情報
    Summary Gran Tierra Energy Inc (Gran Tierra) is an independent energy company. It acquires, explores, and develops oil and gas fields. The company produces crude oil, natural gas, and oil equivalent resources from its fields. Gran Tierra has onshore oil and gas properties in Colombia. It sells oil t …
  • Open Text Corporation:企業の戦略・SWOT・財務分析
    Open Text Corporation - Strategy, SWOT and Corporate Finance Report Summary Open Text Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • TenCate Advanced Armour:企業の戦略・SWOT・財務情報
    TenCate Advanced Armour - Strategy, SWOT and Corporate Finance Report Summary TenCate Advanced Armour - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Universal Biosensors Inc (UBI)-医療機器分野:企業M&A・提携分析
    Summary Universal Biosensors Inc (UBI) is a medical diagnostic company. The company researches, develops and manufactures in vitro diagnostic test devices that are used for professional and consumer point-of-care. The company is working with Siemens Healthcare to develop a range of products for the …
  • Horizon Oil Ltd (HZN):企業の財務・戦略的SWOT分析
    Summary Horizon Oil Ltd (Horizon) is an oil and gas exploration and production company that acquires, explores, develops and produces oil and petroleum properties. The company holds interests in Maari and Manaia fields located in the Taranaki Basin approximately 80 kilometre offshore the north islan …
  • Forty Seven Inc (FTSV):製薬・医療:M&Aディール及び事業提携情報
    Summary Forty Seven Inc (Forty Seven), formerly CD47 Sciences Inc is a clinical-stage immuno-oncology company that focuses on the development of therapies to treat cancer. The company’s lead molecule Hu5F9-G4 is a monoclonal antibody that is used against the CD47 receptor. Its monoclonal antibody is …
  • Echelon Corporation (ELON):企業の財務・戦略的SWOT分析
    Echelon Corporation (ELON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Georgia Power Co (GPW):電力:M&Aディール及び事業提携情報
    Summary Georgia Power Co (Georgia Power), a subsidiary of the Southern Power Company, generates, transmits, distributes and sells electricity. The company produces electricity using various sources of energy such as coal, nuclear, solar, gas and hydro. It supplies electricity in Georgia and to whole …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆